Lung cancer is an important cause of mortality and morbidity world over. Its incidence continues to rise in India and other developing countries. Despite advances in early detection, diagnosis and treatment, the overall survival and outcomes for lung cancer have not changed substantially over the years. Although tobacco smoking remains the most important risk factor for development of lung cancer, association of indoor/outdoor air pollution, occupational exposures and genetic factors with development of this disease has been identified especially amongst non-smokers. A greater understanding of the molecular basis of lung cancer has occurred in the past two decades and has paved the way for development of molecularly targeted therapies which has revolutionized the management of this disease.

The ISSLC (Indian Society for Study of Lung Cancer) continues to be the only professional body in India that is dedicated to the advancement of lung cancer research, education and advocacy. Its membership is open to  medical, surgical and radiation oncologists, pulmonologists, physicians, oncology nurses and other volunteers who have the dedication to work together towards achieving the goal of reducing suffering from lung cancer in India.